Effect evaluation of clinical pathway application in inpatients with chronic severe hepatitis B / 重庆医学

ABSTRACT

Objective To evaluate the effect of clinical pathway(CP) application in inpatients with chronic severe hepatitis B (CSHB).Methods treated from October 2014 to May 2016A total of 182 inpatients with CSHB in the infectious department of a grade A class 3 hospital of Chongqing City were selected and divided into the CP group and non-CP group(NCP).The CP group accepted the standardized treatment strictly according to the procedure set by the CP information system,while the NCP group was implemented the traditional treatment methods.The hospital stay,total hospitalization cost,drug expenses,examination cost,laboratory testing cost,comprehensive medical services and medical material cost were evaluated in the two groups.The master rate of disease knowledge,satisfaction,rate of timely taking medication and outpatient follow-up rate after discharge were investigated and evaluated.Results Compared with the NCP group,the hospital stay length,hospitalization total cost,medication cost,examination cost and laboratory testing cost in the CP group were significantly lower than those in the NCP group(P＜0.05);the patient satisfaction (100.0 ％) and master rate of disease knowledge (97.3 ％) were higher than 96.2 ％ and 92.4 ％ in the NCP group.The rate of regularly taking medication and outpatient follow-up rate after discharge all were 98.7％ in the CP group,which were higher than 95.3 ％ and 92.5％ in the NCP group,and the differences were statistically significant (P＜0.05).Conclusion Implementing CP in the patients with CSHB can obviously shorten the hospitalization days,decreases the hospitalization cost,and improves the patient satisfaction and compliance.